Clustering data with hclust algorithm for (Study ST003984)
Flow induction analysis POSITIVE ION MODE (Analysis AN006561)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 | F16 | F17 | F18 | F19 | F20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAR C0 | ME1051444 | 1.10 | 1.11 | 1.30 | 1.11 | 0.62 | 0.99 | 0.96 | 0.87 | 0.73 | 0.92 | 1.00 | 1.07 | 1.26 | 1.01 | 0.63 | 0.85 | 0.98 | 0.93 | 0.72 | 1.30 |
| CAR C14:1 | ME1051470 | NA | NA | NA | 1.72 | NA | NA | 1.34 | NA | 0.79 | 0.83 | 1.04 | 0.90 | 0.96 | 0.87 | 0.85 | 1.03 | 1.02 | 0.99 | 1.16 | 1.07 |
| CAR C10 | ME1051463 | NA | NA | NA | 0.82 | NA | NA | NA | 0.90 | NA | NA | 1.06 | 1.01 | 0.90 | 1.10 | 1.01 | 0.92 | 1.02 | 0.93 | NA | 1.11 |
| CAR C14:1-OH | ME1051471 | NA | NA | NA | 1.40 | NA | NA | 1.05 | NA | 0.95 | 1.19 | 0.86 | 0.93 | NA | 0.83 | NA | 1.14 | 1.00 | 1.08 | 1.04 | 0.96 |
| CAR C10:1 | ME1051464 | NA | 0.73 | NA | 1.23 | NA | NA | NA | NA | NA | 0.80 | 1.01 | 1.00 | 0.89 | 1.05 | 0.78 | 1.05 | 0.99 | 1.12 | 0.89 | 0.77 |
| CAR C10:2 | ME1051465 | 0.74 | 0.75 | NA | 0.83 | 0.64 | 0.77 | 0.73 | 0.74 | 0.81 | 1.07 | 1.20 | 1.13 | 1.10 | 0.98 | 0.91 | 1.17 | 1.09 | 1.16 | 0.93 | 1.05 |
Factors:
| F1 | Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Luteal |
| F2 | Sample source:Peritoneal fluid | Group:Control | Stage:C | Cycle phase:Proliferative |
| F3 | Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Luteal |
| F4 | Sample source:Peritoneal fluid | Group:Endometriosis | Stage:I | Cycle phase:Proliferative |
| F5 | Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Luteal |
| F6 | Sample source:Peritoneal fluid | Group:Endometriosis | Stage:II | Cycle phase:Proliferative |
| F7 | Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Luteal |
| F8 | Sample source:Peritoneal fluid | Group:Endometriosis | Stage:III | Cycle phase:Proliferative |
| F9 | Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Luteal |
| F10 | Sample source:Peritoneal fluid | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative |
| F11 | Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Luteal |
| F12 | Sample source:Plasma | Group:Control | Stage:C | Cycle phase:Proliferative |
| F13 | Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Luteal |
| F14 | Sample source:Plasma | Group:Endometriosis | Stage:I | Cycle phase:Proliferative |
| F15 | Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Luteal |
| F16 | Sample source:Plasma | Group:Endometriosis | Stage:II | Cycle phase:Proliferative |
| F17 | Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Luteal |
| F18 | Sample source:Plasma | Group:Endometriosis | Stage:III | Cycle phase:Proliferative |
| F19 | Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Luteal |
| F20 | Sample source:Plasma | Group:Endometriosis | Stage:IV | Cycle phase:Proliferative |
